Form 4: Usana Health Sciences Executive Reports Stock Transaction
Insider Transaction (Form 4)
Kathryn Michelle Armstrong, CHIEF SCIENTIFIC OFFICER of Usana Health Sciences Inc, reported multiple transactions in common stock on July 25, 2026.
Summary
- Option exercise/conversion: acquired 1,166 Common Stock on July 25, 2026; holds 3,989 after (Direct).
- Tax/exercise-price withholding: disposed of 518 Common Stock at $21.32 ($11,044) on July 25, 2026; holds 3,471 after (Direct).
- Option exercise/conversion: disposed of 1,166 Restricted Stock Units on July 25, 2026; holds 39,426 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kathryn Michelle Armstrong — Officer (CHIEF SCIENTIFIC OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-25 | Option exercise/conversion | Common Stock | 1,166 | — | — | 3,989 |
| 2026-07-25 | Tax/exercise-price withholding | Common Stock | 518 | $21 | $11.0K | 3,471 |
| 2026-07-25 | Option exercise/conversion | Restricted Stock Units | 1,166 | — | — | 39,426 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-25 | Option exercise/conversion (1,166 shares) |
| 2026-07-25 | Tax/exercise-price withholding (518 shares) |
| 2026-07-25 | Option exercise/conversion (1,166 shares) |
Keywords
insider transaction, Form 4, USNA, USANA HEALTH SCIENCES INC, neutral, Kathryn Michelle Armstrong
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.